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HLA-A 31:01 is not associated with the 
development of methotrexate pneumonitis in 
the UK population: results from a genome-wide 
association study
We read with interest the article by Furukawa et al1 suggesting an 
association between HLA-A 31:01 and methotrexate (MTX)-in-
duced interstitial lung disease (ILD) in Japanese patients with 
rheumatoid arthritis (RA). MTX-ILD or MTX-pneumonitis 
(MTX-P) is an idiosyncratic hypersensitivity reaction to MTX 
that usually occurs within the first year of MTX therapy, 
inducing inflammation, cytokine release and the activation of 
CD4+ T-lymphocytes within the lung parenchyma,2–4 with 
a reported prevalence of 1% of the Caucasian RA population 
prescribed MTX.5
To investigate this association further, we conducted a 
genome-wide association study. Rheumatologists working 
within the National Health Service in the UK identified 
Caucasian patients with RA, who developed clinician diag-
nosed MTX-P (n=65). Caucasian controls, matched for age 
and gender, were identified from a prospective observational 
cohort study of patients starting MTX (n=195). In order to 
be eligible, controls were required to have 1 year of contin-
uous MTX therapy without the development of MTX-P. 
Assuming HLA-A 31:01 prevalence of 3.6% in the European 
Caucasian population,6 this provided 80% power to detect 
an OR of 3.0. Genotyping was performed using the Illumina 
Infinium HumanCoreExome 12 BeadChip genome-wide array 
(Illumina, San Diego, USA); HLA-A 31:01 was imputed using 
SNP2HLA7 and a subset of samples (n=24) were directly 
genotyped for the allele using an established wet-lab technique 
described previously.8
Following quality control, data for 62 cases and 175 
controls remained. HLA-A 31:01 was not associated with 
MTX-P in this cohort (p=0.21). Wet-lab genotyping of a 
subset of samples confirmed concordance with in silico impu-
tation (κ=1.00). One locus, rs6593803 mapping to an inter-
genic region between the GJA5 and ACP6 genes, was associ-
ated with MTX-P, however, the results did not reach genome-
wide significance thresholds for claims of confirmed associa-
tion (p=1.85×10−7, OR=3.13).9 Nonetheless, rs6593803 is 
known to affect the expression of GJA5.10 GJA5 is a member of 
the connexin gene family and the resulting protein is connexin 
40. The connexin 40 protein is a component of gap junc-
tions that act at sites of cell–cell contact allowing diffusion of 
signalling molecules between cells.11 Transgenic mice deficient 
in connexin 40 and 43 (cx40−/−/cx43−/−) have a reduced life 
span due to lung abnormalities including pulmonary fibrosis, 
alveolar wall thickening and increased lung fibroblasts,12 
histopathological findings similar to MTX-P.13
In summary, we have found no evidence of association 
between HLA-A 31:01 and MTX-P in a European population. 
Three loci reached suggestive evidence for association with 
MTX-P (rs6593803 (p=1.85×10−7, OR=3.13), rs9299346 
(p=1.76×10−6, OR=2.76) and rs1624005 (p=6.54×10−6, 
OR=2.59)), but further studies with larger numbers of patients 
with this rare disease are required to confirm these non-HLA 
associations with MTX-P.
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